<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03582852</url>
  </required_header>
  <id_info>
    <org_study_id>2017-43</org_study_id>
    <secondary_id>2017-A02650-53</secondary_id>
    <nct_id>NCT03582852</nct_id>
  </id_info>
  <brief_title>Laparoscopic Sacrocolpexy Versus Lateral Suspension</brief_title>
  <acronym>SUSPENSION</acronym>
  <official_title>Laparoscopic Sacrocolpexy Versus Lateral Suspension With a Mesh for the Treatment of Pelvic Organ Prolapse : a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical treatment of genital prolapse can be performed by laparoscopic surgery or by vaginal
      surgery, with or without using meshes. Laparoscopic sacrocolpopexy, which consist in fixing a
      mesh between vaginal anterior wall and the promontory is the gold standard procedure to treat
      anterior prolapse or of the vaginal vault. Most of studies shows a success rate of 80% of
      this procedure.

      However, access to the promontory could be difficult in patients because of adherences or
      anatomical reasons. This step of the procedure also exposes to risk of ureteral or vascular
      injuries. Recent issues have also found spondylodiscitis cases.

      The technique of laparoscopic lateral suspension with mesh was developed by Dubuisson in 1998
      allows not to have to approach the promontory and avoids both the risk of vascular injury and
      ureteral damage of laparoscopic sacrocolpopexy. Instead of attach the mesh to the promontory,
      the procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the
      anterior abdominal wall. The aim of this study is to compare the clinical and functional
      efficiency of the lateral suspension versus laparoscopic sacrocolpopexy.

      It is a prospective, randomized, monocentric study compared two groups The study hypothesis
      is that the lateral suspension would provide correction than the laparoscopic sacrocolpopexy.

      The primary outcome is the comparison of anatomic correction rates at 1 year Success is
      defined as 1 year Ba et C points &lt; -1 centimeter in POP-Q international score.

      Secondary endpoints are improve of quality of life evaluated with the validated P-QOL
      questionnaire, and complications rates, including post-operative posterior prolapse.

      Number of subjects required is 72 patients, 36 in each group having a laparoscopic
      sacrocolpopexy or lateral suspension.

      Outcomes will be evaluated at 1 month and 1 year post-operative consultation
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2018</start_date>
  <completion_date type="Anticipated">April 11, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 11, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate cervico-urethral hypermobility</measure>
    <time_frame>one year</time_frame>
    <description>Success is defined by two points inferior at 1 centimeter in Pelvic organs prolapse quantification (POP-Q) international score. defining a symptomatic or asymptomatic state</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>promontory</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic sacrocolpopexy, which consist in fixing a mesh between vaginal anterior wall</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic lateral suspension</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the anterior abdominal wall</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical treatment of genital prolapse</intervention_name>
    <description>Laparoscopy performed according to the usual technique of the participating center with pneumoperitoneum between 12 and 15 mmHg. Placement of the 5 mm trocar operator left and right iliac fossa and 5 mm pubic addition.</description>
    <arm_group_label>laparoscopic lateral suspension</arm_group_label>
    <arm_group_label>promontory</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients at least 18 years old.

          -  Patients who agreed to participate in the study and signed informed consent.

          -  Patient affiliated to a social protection system.

          -  Surgical indication by laparoscopy of prolapse cure symptomatic of the anterior stage
             and / or isolated medium.

        Exclusion Criteria:

          -  Minor patient.

          -  Patient refusing to sign the consent or unable to receive the necessary information to
             give informed consent.

          -  Patient not affiliated to a social protection system.

          -  Presence of one or more contraindication (s) to laparoscopy

          -  Presence of posterior prolapse requiring surgical treatment

          -  Need for an associated surgical procedure.

          -  Major people under legal protection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Olivier ARNAUD, Director</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aubert AGOSTINI, PU-PH</last_name>
    <phone>491383785</phone>
    <phone_ext>+33</phone_ext>
    <email>aubert.agostini@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire TOURETTE, PH</last_name>
    <phone>491383785</phone>
    <phone_ext>+33</phone_ext>
    <email>claire.tourette@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aubert AGOSTINI, PU-PH</last_name>
      <phone>491383785</phone>
      <phone_ext>+33</phone_ext>
      <email>aubert.agostini@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>PH</last_name>
      <phone>491383785</phone>
      <phone_ext>+33</phone_ext>
      <email>claire.tourette@ap-hm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Aubert AGOSTINI, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire TOURETTE, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 22, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2018</study_first_posted>
  <last_update_submitted>June 27, 2018</last_update_submitted>
  <last_update_submitted_qc>June 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

